PTGX: Rega marang dodolan Protagonist Therapeutics Inc
Protagonist Therapeutics develops innovative oral therapies for blood and gastrointestinal disorders, replacing injections. This price-to-sales chart illustrates current trends, with the value holding around 15.90. High margins from synthesized patents provide an economy of scale. Business prospects rely on the success of rusfertide and strategic collaboration with major partners to generate royalties.
Protagonist Therapeutics Inc (PTGX) - rincian metrik lan laporan keuangan
- rega saham lan target rega konsensus:
- informasi kapitalisasi pasar:
- data nilai buku modal saham:
- indikator beban kredit lan likuiditas emiten:
Utang marang Modal Protagonist Therapeutics|PTGX - Rasio utang jangka dawa marang ekuitas|Rasio silihan jangka cendhak marang modal Protagonist Corp|PTGX - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Protagonist Therapeutics Inc|PTGX - Utang jangka dawa perusahaan|Tanggungan jangka cendhak Protagonist Therapeutics|Likuiditas darurat protagonist-inc.com
- indikator bathi lan kelipatan valuasi:
PTGX - Bathi resik perusahaan|Prakiraan bathi resik Protagonist Therapeutics|PTGX - Pangali P/E|Kapitalisasi marang proyeksi bathi Protagonist Therapeutics, Inc.|PTGX - Rasio rega marang bathi tumrap wutah|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Protagonist Therapeutics Inc|PTGX - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone patang kuartal pungkasan Protagonist Therapeutics|PTGX - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan protagonist-inc.com|PTGX - Wutah bathi resik saben saham ing taun iki|Proyeksi tambahing bathi saben saham ing taun ngarep Protagonist Therapeutics
- data total pendapatan lan volume dodolan:
Analisis umum perusahaan:PTGX protagonist-inc.com
The P/S ratio reflects the market value of a business relative to its sales volume, allowing investors to determine the extent of overpayment for an asset amid inflationary pressures. When analyzing the price-to-sales valuation on GURU.Markets, it is critical to consider that Protagonist Therapeutics (PTGX) expenditures on costly cold-chain peptide logistics impact margins, making this indicator key to monitoring capitalization efficiency.
Perusahaan pesaing
argenx.com - Rasio kapitalisasi marang pendapatan|Multiplikator P/S BNTX (BioNTech)|Abivax Pharma (ABVX) - Rega marang dodolan|ADMA - Rasio rega marang pendapatan|Rasio rega marang dodolan IMVT|Kiniksa Pharmaceuticals (KNSA) - Rasio rega marang pendapatan|grifols.com - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Adaptive Biotechnologies Corporation|Rega marang dodolan Celldex Therapeutics Inc CLDX|Kapitalisasi marang pendapatan AUPH (Aurinia Pharma)|Kapitalisasi marang volume dodolan BCRX|Multiplikator P/S VERA (Vera Therapeutics, Inc.)|Multiplikator P/S dianthustx.com DNTH|Pharvaris - Multiplikator P/S|Multiplikator rega marang pendapatan AbCellera Biologics Inc. (ABCL)|Tourmaline Corp (TRML) - Rasio rega marang pendapatan|Rega marang dodolan Precigen Corp (PGEN)|Rasio rega marang pendapatan Pharming Group N.V.|Rasio kapitalisasi marang pendapatan NKTR (nektar.com)|Multiplikator P/S UPB|Koefisien rega marang pendapatan Zenas Bio|Rasio rega marang pendapatan Immunome Corp IMNM|Koefisien rega marang pendapatan Gossamer Bio Corp. (GOSS)|KALV: Kapitalisasi marang pendapatan|septerna.com - Kapitalisasi marang volume dodolan|PVLA (Pieris Pharmaceuticals, Inc.) - Kapitalisasi marang pendapatan|Savara Inc - Rasio kapitalisasi pasar marang pendapatan|Kapitalisasi marang pendapatan RIGL|ANAB (AnaptysBio Inc.) - Kapitalisasi marang volume dodolan|Multiplikator P/S ATXS|ENGN (engene.com) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S RAPT (RAPT Therapeutics)|Aerovate Therapeutics, Inc. (JBIO) - Rega marang dodolan|ACRS - Rasio rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan KYTX (Kyverna Therapeutics, Inc)|TLSA: Multiplikator P/S|cabalettabio.com (CABA) - Multiplikator P/S|Rasio rega marang pendapatan Ventyx Biosciences, Inc.|Theratechnologies, Inc. - Rasio rega marang dodolan|Multiplikator P/S AVTX|ELDN - Rega marang dodolan|Agenus - Kapitalisasi marang pendapatan|Multiplikator P/S climbbio.com CLYM|ZURA: Kapitalisasi marang pendapatan|aTyr Pharma Inc - Kapitalisasi marang volume dodolan|ADAG: Multiplikator P/S|IMA - Koefisien rega marang pendapatan|STTK (Shattuck Labs Inc) - Multiplikator P/S|Kapitalisasi marang pendapatan Equillium Bio (EQ)|Rasio rega marang pendapatan Connect Biopharma (CNTB)|Koefisien rega marang pendapatan immunic-therapeutics.com|Rasio rega marang pendapatan Atara Bio ATRA|IFRX (InflaRx NV) - Rasio rega marang dodolan|XFOR: Kapitalisasi marang pendapatan|Adicet Bio - Kapitalisasi marang volume dodolan|CELU: Multiplikator P/S|Multiplikator rega marang pendapatan INmune Bio Inc INMB|Kapitalisasi marang pendapatan BRNS|Rasio kapitalisasi marang pendapatan KZR (Kezar Life Sciences Inc)|Rasio rega marang pendapatan SAB Biotherapeutics (SABS)|AKTX: Rasio rega marang dodolan|Multiplikator P/S ENLV (Enlivex Therapeutics Ltd.)|Rasio kapitalisasi pasar marang pendapatan QTTB|GeoVax Labs Inc - Multiplikator P/S|EDSA - Multiplikator P/S|iBio, Inc. (IBIO) - Rasio rega marang pendapatan|Carisma Therapeutics Inc. - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan XTL Biopharmaceuticals Ltd.|Kapitalisasi marang pendapatan Bolt Bio (BOLT)|Multiplikator P/S HCWB|Multiplikator P/S aptevotherapeutics.com (APVO)|AIM ImmunoTech Inc. - Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan ADTX|GRI Bio - Multiplikator P/S|Koefisien rega marang pendapatan XORTX Therapeutics Inc XRTX|ReShape Lifesciences (HIND) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan Revelation Biosciences Corp|Rasio rega marang pendapatan Indaptus Therapeutics|Kapitalisasi marang pendapatan scinai.com (SCNI)|Kapitalisasi marang pendapatan CALI (CalciMedica, Inc.)|Multiplikator P/S affimed.com (AFMD)|Rasio rega marang pendapatan Allakos ALLK|HOOK: Rasio kapitalisasi marang pendapatan|IGM Bio - Multiplikator P/S|Rega marang dodolan iteostherapeutics.com|Ocean Biomedical (OCEA) - Rasio rega marang pendapatan|Rasio rega marang dodolan TCBP (TC BioPharm (Holdings) Plc)|Rasio rega marang pendapatan Third Harmonic Bio, Inc
